The partners reported this week that clinical trials have shown that a regimen consisting of half a dose of the vaccine, followed a full month and a month later, is more effective than two full doses. Dr Katherine O’Brien, WHO Director for Immunization, Vaccines and Biological Agents, emphasized the need for further evaluation, presenting the data in a press release. Worldwide experience with the storage and distribution of Ebola vaccine may provide information on possible COVID-19 inoculation, according to the WHO.
This news content is a computer generated summarized version of the original article and the authenticity of the original content has not been verified. Please click on the View Article button to refer to the actual content.